Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Autris (AUTR)
Los Angeles, CA, US
Autris, through its subsidiary NitroHeat, LLC, manufactures and distributes a range of specialized industrial equipment, including nitrogen generators, sophisticated air filtration systems, compressed air heaters, and heated hoses. Their flagship products feature the NitroMax30, a nitrogen generator delivering 30 cubic feet per minute of high-purity nitrogen, and the HeatPro200, which warms compressed air or nitrogen up to 200 degrees Fahrenheit. For critical applications like painting and powder coating that demand clean, dry air, the MaxDry200 offers an integrated solution combining a tri-stage filter, membrane dryer, and heater. Heated hoses are also provided as integral parts of the HeatPro200 and MaxDry200 systems. Autris supplies its offerings to a broad spectrum of clients, encompassing automotive and industrial paint service providers, industrial component manufacturers, and auto collision facilities. This distribution is facilitated by a robust network across the United States, Canada, the Netherlands, Germany, and China. The company's operations are headquartered in Los Angeles, California.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | -1.01% | -5.60% | -16.55% | -13.24% | +293.33% | +147,400.00% | +5,263.64% | +4,438.46% | +247.06% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Chemicals - Specialty: +4.7%+383.0% ★ Q4'25: -59.9% (vs Q4'24)
-
EPS growth Chemicals - Specialty: +13.2%+48.2% ★ Q4'25: -350.0% (vs Q4'24)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-19.1% Q4'25: -3,500.4% (vs Q4'24)
-
EBIT margin Chemicals - Specialty: +8.8%-34.8% Q4'25: -420.6% (vs Q4'24)
-
ROIC Chemicals - Specialty: +5.6%-2.3% Q4'25: -2.1% (vs Q4'24)
-
Share dilution Chemicals - Specialty: +0.1%+120.8% Q4'25: +161.6% (vs Q4'24)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×-2.39× Q4'25: -21.47× (vs Q4'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-22 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Wolf Capital Corp. | 3.62M | 8.50% | 3.62M | — | 3.62M | — | CO | Cayman Islands | 2014-12-12 | ↗ |
| 2 | Lindsay Capital Corp. | 2.93M | 6.90% | 2.93M | — | 2.93M | — | CO | Cayman Islands | 2014-12-08 | ↗ |
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Anand Derek Naidoo | Chief Executive Officer, President & Director | 60.0K | male |
| Ellis Martin | Director | 30.0K | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for AUTR
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
